Multicentre Evaluation Of A Clinical Pathway For Chronic Cough In Children- Can Its Use Improve Clinical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$971,362.00
Summary
Chronic cough is a common presenting symptom to doctors. It is associated with significant morbidity and may be a symptom of a serious underlying problem. This is especially pertinent to Aboriginal children. In this study we will examine the utility and efficacy of an evidence based clinical pathway for the management of chronic cough in Aboriginal and non-Aboriginal children. This study will contribute to clinical policy and improve clinical outcomes and early diagnosis of respiratory illnesses
Antecedents Of Renal Disease In Aboriginal Children And Young Adults - 12 Year Follow-up
Funder
National Health and Medical Research Council
Funding Amount
$1,845,061.00
Summary
Aboriginal Australians have 2 to 10 times the rate of chronic kidney disease and premature death from cardiovascular disease compared with non-Aboriginal Australians. Our 6 year follow-up of Aboriginal children from diverse NSW areas has shown no increase in risk for these diseases when compared with non-Aboriginal children. The ARDAC Second Phase Study will follow the participants for another 6 years to determine whether these health disparities start to manifest in young Aboriginal adults.
Is Long Term Weekly Azithromycin Use For Bronchiectasis In Indigenous Children Associated With Antibiotic Resistance?
Funder
National Health and Medical Research Council
Funding Amount
$398,663.00
Summary
Aboriginal children living in remote areas such as central Australia experience unacceptably high rates of respiratory infection which can become chronic. A randomised controlled trial is being conducted to see if long-term azithromycin therapy reduces respiratory exacerbations in Aboriginal children with chronic lung disease. Concerns about the development of antibiotic resistance need to be addressed. This project aims to determine if such treatment is associated with antibiotic resistance.
A Randomised Controlled Trial Of A Family Tobacco Control Program To Reduce Respiratory Illness In Indigenous Infants
Funder
National Health and Medical Research Council
Funding Amount
$1,157,688.00
Summary
Over 60% of Indigenous children live in households with one or more regular smokers, where they are exposed to high levels of environmental tobacco smoke (ETS). ETS is a significant and preventable cause of respiratory illness. The aim of this research project is to test whether a family-based program about ETS smoke will reduce the number of clinic presentations of infants for respiratory illness. If successful, it has the potential to improve the health of Indigenous children across Australia.